We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Projects granted during 2016 that have a primary purpose of translational applied research - human cardiovascular disorders.
Cardiovascular diseases (CVDs) are one of the leading causes of death and disability in the world
Update of cardiovascular disease (CVD) profile indicators for heart disease, diabetes, kidney disease and stroke data for commissioning organisations.
Projects granted during 2014 that have a primary purpose of basic research into the cardiovascular, blood and lymphatic system.
Update of cardiovascular disease (CVD) profile indicators for stroke data for clinical commissioning groups.
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
The outcomes versus expenditure tool shows the relationship between spending on cardiovascular disease (CVD) care and clinical outcomes.
Projects granted during 2015 that have a primary purpose of translational and applied research: cardiovascular disorders.
Projects granted during 2015 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.
Update of information on diabetes in the cardiovascular disease (CVD) profiles.
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
This study aims to estimate the costs of Cardiovascular Disease and the costs of Diabetes Mellitus to individuals and society
Sets out Public Health England's (PHE) initiatives for cardiovascular disease (CVD) prevention.
Hypertension and diabetes are major risk factors for cardiovascular disease (CVD)
An exploratory study from Zhejiang, China
This policy brief shares findings from a pragmatic, cluster randomised controlled trial in Zhejiang province, China
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).